June 22, 2020
Investors' pandemic-driven appetites for shares of newly listed biopharmaceutical companies seem to know no bounds in 2020. Royalty Pharma (Tii:RPRX) made its stock market debut at $44 per share on Tuesday, valuing the company at a whopping $26.2 billion and the market pushed the stock more than 60% higher during its first day of trading.
A Walmart (Tii:WMT) in Fayetteville, Arkansas is reimagining the shopping experience during the coronavirus pandemic by using self-checkout counters only, in lieu of traditional cashier lanes.
Starting with its facility in Kent, Washington, Amazon (Tii:AMZN) will begin deploying devices - shaped like clear plastic sleeves - that emit a loud beeping noise and flashing lights when workers are too close to one another.
The chief executive of fintech giant Wirecard AG (Tii:WCAGY) resigned Friday after two banks in the Philippines meant to be holding over $2 billion on behalf of the company said they don’t have the cash and never did.
Canada, Shopify (Tii:SHOP) and BlackBerry (Tii:BB) announced a coronavirus contact tracing app - developed with provincial and federal governments - expected to launch in July. The app, called COVID Alert, will use Bluetooth connections to swap randomly generated codes with users in a geographic vicinity.
While Nikola (Tii:NKLA) and Tesla (Tii:TSLA) have charged up investors' enthusiasm for electric vehicles (EV) recently, they'll soon have to share the stage. Committed to developing electrified powertrain solutions for Class 8 commercial vehicles, Hyliion announced today that it's preparing to hit the public market toward the end of the third quarter of 2020.